Analysis of HIF-prolyl hydroxylases binding to substrates

被引:32
|
作者
Landazuri, Manuel O.
Vara-Vega, Alicia
Viton, Mariano
Cuevas, Yolanda
del Peso, Luis
机构
[1] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, Madrid 28029, Spain
[2] Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, Madrid 28029, Spain
关键词
HIF; EGLN; PHD; hypoxia; proline-hydroxylation; VHL;
D O I
10.1016/j.bbrc.2006.09.170
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypoxia inducible transcription factors (HIF) are mainly regulated by a group of proline hydroxylases (EGLNs) that, in the presence of oxygen, target HIF for degradation. HIF alpha contains two independent oxygen degradation domains (N-ODD and C-ODD) that are substrates for these enzymes. In this work, we employed the yeast two-hybrid assay to study the sequence determinants required for the binding of EGLN1 and 3 to HIF1 alpha in a cellular context. Our results demonstrate that, while EGLN1 is able to recognize both ODDs within full length HIF1 alpha protein, EGLN3 only binds to CODD. The analysis of the residue substitutions within CODD uncovered novel critical determinants for EGLN1 and 3 binding. In addition, our results show that both enzymes have a very similar, albeit not identical, residue preference at specific positions in their substrate sequences. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 50 条
  • [21] Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases
    Schlemminger, I
    Mole, DR
    McNeill, LA
    Dhanda, A
    Hewitson, KS
    Tian, YM
    Ratcliffe, PJ
    Pugh, CW
    Schofield, CJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (08) : 1451 - 1454
  • [22] Catalytic mechanism and substrate specificity of HIF prolyl hydroxylases
    Smirnova, N. A.
    Hushpulian, D. M.
    Speer, R. E.
    Gaisina, I. N.
    Ratan, R. R.
    Gazaryan, I. G.
    [J]. BIOCHEMISTRY-MOSCOW, 2012, 77 (10) : 1108 - 1119
  • [23] Catalytic mechanism and substrate specificity of HIF prolyl hydroxylases
    N. A. Smirnova
    D. M. Hushpulian
    R. E. Speer
    I. N. Gaisina
    R. R. Ratan
    I. G. Gazaryan
    [J]. Biochemistry (Moscow), 2012, 77 : 1108 - 1119
  • [24] Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase
    Yum, Soohwan
    Jeong, Seongkeun
    Kim, Dohoon
    Lee, Sunyoung
    Kim, Wooseong
    Yoo, Jin-Wook
    Kim, Jung-Ae
    Kwon, Oh Sang
    Kim, Dae-Duk
    Min, Do Sik
    Jung, Yunjin
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [25] Multimodal Imaging Reveals that Sustained Inhibition of HIF-Prolyl Hydroxylases Induces Opposing Effects on Right and Left Ventricular Function in Healthy Rats
    Gain Robinson
    Mark Zielstorff
    Raquel Sevilla
    Amy Vanko
    Christopher Sinz
    Milenko Cicmil
    Weisheng Zhang
    Kimberly Bettano
    [J]. Molecular Imaging and Biology, 2024, 26 : 179 - 187
  • [26] Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion
    Yeoh, Kar Kheng
    Chan, Mun Chiang
    Thalhammer, Armin
    Demetriades, Marina
    Chowdhury, Rasheduzzaman
    Tian, Ya-Min
    Stolze, Ineke
    McNeill, Luke A.
    Lee, Myung Kyu
    Woon, Esther C. Y.
    Mackeen, Mukram M.
    Kawamura, Akane
    Ratcliffe, Peter J.
    Mecinovic, Jasmin
    Schofield, Christopher J.
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2013, 11 (05) : 732 - 745
  • [27] A conserved family of prolyl-4-hydroxylases that modify HIF
    Bruick, RK
    McKnight, SL
    [J]. SCIENCE, 2001, 294 (5545) : 1337 - 1340
  • [28] Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening
    Mahesh Kumar Teli
    G. K. Rajanikant
    [J]. Molecular Diversity, 2012, 16 : 193 - 202
  • [29] HIF Prolyl 4-Hydroxylases and their Potential as Drug Targets
    Myllyharju, Johanna
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (33) : 3878 - 3885
  • [30] Tissue-Specific Expression of Fetal HIF Prolyl Hydroxylases
    Zutel, M.
    Hoppe, G.
    Sears, J. E.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)